Vishnu Manchu's mythological film 'Kannappa' has successfully crossed Rs 23 crore at the box office in its opening weekend. Discover the film's performance across languages, audience reactions ...

‘Sardaar Ji 3’ box office collection: Diljit Dosanjh-starrer breaks records, registers big numbers globally The absence of a domestic release due to political tensions has not dimmed the film ...

On Kannappa's day 3 and Kuberaa's day 10, both films followed different paths on BMS - Sunday box office early trends.

Kajol's Maa has jumped further on day 3 and the BMS sales are promising great numbers already - Sunday occupancy and sales report.

What is today’s moon phase? As of Thursday, July 3, the moon phase is Waxing Gibbous. According to NASA's Daily Moon Observation, 57% of the moon will be lit up and visible to us on Earth.

Maa Box Office Collection Day 3: Kajor starrer film ‘Maa’ has performed decently after the first two days at the box office and earned an estimated ₹ 10.83 crore in India.

Maa Box Office Collection: Kajol starrer mythological horror wraps up its first weekend with over Rs 17 crore. The film now eyes to cross Rs 20 crore mark.

The government recently announced its plan for Phase 1 of Awaab’s Law, a new piece of legislation which will come into force on 27 October 2025. It introduces strict, legally-binding timeframes for ...

At a time in the post-pandemic box office, particularly during a post-Christmas when most of the country was in a deep-freeze, M3GAN seduced.

The government recently announced its plan for Phase 1 of Awaab’s Law, a new piece of legislation which will come into force on October 27. It introduces strict, legally-binding timeframes for ...

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.

Armed with results from a phase 2 trial, Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor ...